Pathway ID |
Pathway Class |
Description |
#PolymiRTS |
|
Endocrine and metabolic diseases |
Type II diabetes mellitus |
26 |
|
Endocrine and metabolic diseases |
Type I diabetes mellitus |
9 |
|
Endocrine and metabolic diseases |
Maturity onset diabetes of the young |
5 |
|
Neurodegenerative diseases |
Alzheimer's disease |
93 |
|
Neurodegenerative diseases |
Parkinson's disease |
68 |
|
Neurodegenerative diseases |
Amyotrophic lateral sclerosis (ALS) |
25 |
|
Neurodegenerative diseases |
Huntington's disease |
101 |
|
Neurodegenerative diseases |
Prion diseases |
18 |
|
Infectious diseases: Bacterial |
Bacterial invasion of epithelial cells |
49 |
|
Infectious diseases: Bacterial |
Vibrio cholerae infection |
25 |
|
Infectious diseases: Bacterial |
Epithelial cell signaling in Helicobacter pylori infection |
31 |
|
Infectious diseases: Bacterial |
Pathogenic Escherichia coli infection |
37 |
|
Infectious diseases: Bacterial |
Shigellosis |
50 |
|
Infectious diseases: Parasitic |
Leishmaniasis |
31 |
|
Cancers: Overview |
Pathways in cancer |
203 |
|
Cancers: Specific types |
Colorectal cancer |
54 |
|
Cancers: Specific types |
Renal cell carcinoma |
57 |
|
Cancers: Specific types |
Pancreatic cancer |
60 |
|
Cancers: Specific types |
Endometrial cancer |
42 |
|
Cancers: Specific types |
Glioma |
47 |
|
Cancers: Specific types |
Prostate cancer |
71 |
|
Cancers: Specific types |
Thyroid cancer |
25 |
|
Cancers: Specific types |
Basal cell carcinoma |
21 |
|
Cancers: Specific types |
Melanoma |
45 |
|
Cancers: Specific types |
Bladder cancer |
36 |
|
Cancers: Specific types |
Chronic myeloid leukemia |
60 |
|
Cancers: Specific types |
Acute myeloid leukemia |
45 |
|
Cancers: Specific types |
Small cell lung cancer |
56 |
|
Cancers: Specific types |
Non-small cell lung cancer |
45 |
|
Immune diseases |
Asthma |
1 |
|
Immune diseases |
Autoimmune thyroid disease |
5 |
|
Immune diseases |
Systemic lupus erythematosus |
50 |
|
Immune diseases |
Allograft rejection |
5 |
|
Immune diseases |
Graft-versus-host disease |
7 |
|
Immune diseases |
Primary immunodeficiency |
5 |
|
Cardiovascular diseases |
Hypertrophic cardiomyopathy (HCM) |
40 |
|
Cardiovascular diseases |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) |
38 |
|
Cardiovascular diseases |
Viral myocarditis |
29 |
Pathway ID |
Pathway Class |
Description |
#PolymiRTS |
|
Carbohydrate metabolism |
Glycolysis / Gluconeogenesis |
33 |
|
Carbohydrate metabolism |
Citrate cycle (TCA cycle) |
20 |
|
Carbohydrate metabolism |
Pentose phosphate pathway |
16 |
|
Carbohydrate metabolism |
Pentose and glucuronate interconversions |
3 |
|
Carbohydrate metabolism |
Fructose and mannose metabolism |
19 |
|
Carbohydrate metabolism |
Galactose metabolism |
13 |
|
Carbohydrate metabolism |
Ascorbate and aldarate metabolism |
5 |
|
Lipid metabolism |
Fatty acid biosynthesis |
4 |
|
Lipid metabolism |
Fatty acid metabolism |
24 |
|
Lipid metabolism |
Synthesis and degradation of ketone bodies |
5 |
|
Lipid metabolism |
Steroid biosynthesis |
11 |
|
Lipid metabolism |
Primary bile acid biosynthesis |
5 |
|
Metabolism of cofactors and vitamins |
Ubiquinone and other terpenoid-quinone biosynthesis |
2 |
|
Lipid metabolism |
Steroid hormone biosynthesis |
5 |
|
Energy metabolism |
Oxidative phosphorylation |
61 |
|
Nucleotide metabolism |
Purine metabolism |
69 |
|
Biosynthesis of other secondary metabolites |
Caffeine metabolism |
2 |
|
Nucleotide metabolism |
Pyrimidine metabolism |
51 |
|
Amino acid metabolism |
Alanine, aspartate and glutamate metabolism |
19 |
|
Amino acid metabolism |
Glycine, serine and threonine metabolism |
13 |
|
Amino acid metabolism |
Cysteine and methionine metabolism |
18 |
|
Amino acid metabolism |
Valine, leucine and isoleucine degradation |
28 |
|
Amino acid metabolism |
Valine, leucine and isoleucine biosynthesis |
7 |
|
Amino acid metabolism |
Lysine biosynthesis |
1 |
|
Amino acid metabolism |
Lysine degradation |
31 |
|
Amino acid metabolism |
Arginine and proline metabolism |
27 |
|
Amino acid metabolism |
Histidine metabolism |
8 |
|
Amino acid metabolism |
Tyrosine metabolism |
9 |
|
Amino acid metabolism |
Phenylalanine metabolism |
5 |
|
Amino acid metabolism |
Tryptophan metabolism |
13 |
|
Amino acid metabolism |
Phenylalanine, tyrosine and tryptophan biosynthesis |
2 |
|
Metabolism of other amino acids |
beta-Alanine metabolism |
10 |
|
Metabolism of other amino acids |
Taurine and hypotaurine metabolism |
2 |
|
Metabolism of other amino acids |
Cyanoamino acid metabolism |
3 |
|
Metabolism of other amino acids |
D-Glutamine and D-glutamate metabolism |
2 |
|
Metabolism of other amino acids |
Glutathione metabolism |
20 |
|
Carbohydrate metabolism |
Starch and sucrose metabolism |
11 |
|
Glycan biosynthesis and metabolism |
N-Glycan biosynthesis |
24 |
|
Glycan biosynthesis and metabolism |
Other glycan degradation |
4 |
|
Carbohydrate metabolism |
Amino sugar and nucleotide sugar metabolism |
22 |
|
Biosynthesis of other secondary metabolites |
Butirosin and neomycin biosynthesis |
1 |
|
Glycan biosynthesis and metabolism |
Glycosaminoglycan degradation |
9 |
|
Lipid metabolism |
Glycerolipid metabolism |
22 |
|
Carbohydrate metabolism |
Inositol phosphate metabolism |
25 |
|
Glycan biosynthesis and metabolism |
Glycosylphosphatidylinositol(GPI)-anchor biosynthesis |
10 |
|
Lipid metabolism |
Glycerophospholipid metabolism |
29 |
|
Lipid metabolism |
Ether lipid metabolism |
7 |
|
Lipid metabolism |
Arachidonic acid metabolism |
13 |
|
Lipid metabolism |
Linoleic acid metabolism |
3 |
|
Lipid metabolism |
alpha-Linolenic acid metabolism |
4 |
|
Lipid metabolism |
Sphingolipid metabolism |
14 |
|
Glycan biosynthesis and metabolism |
Glycosphingolipid biosynthesis - lacto and neolacto series |
5 |
|
Glycan biosynthesis and metabolism |
Glycosphingolipid biosynthesis - globo series |
7 |
|
Glycan biosynthesis and metabolism |
Glycosphingolipid biosynthesis - ganglio series |
5 |
|
Carbohydrate metabolism |
Pyruvate metabolism |
23 |
|
Carbohydrate metabolism |
Glyoxylate and dicarboxylate metabolism |
7 |
|
Carbohydrate metabolism |
Propanoate metabolism |
19 |
|
Carbohydrate metabolism |
Butanoate metabolism |
18 |
|
Metabolism of cofactors and vitamins |
One carbon pool by folate |
11 |
|
Energy metabolism |
Methane metabolism |
5 |
|
Metabolism of cofactors and vitamins |
Thiamine metabolism |
4 |
|
Metabolism of cofactors and vitamins |
Riboflavin metabolism |
6 |
|
Metabolism of cofactors and vitamins |
Vitamin B6 metabolism |
3 |
|
Metabolism of cofactors and vitamins |
Nicotinate and nicotinamide metabolism |
10 |
|
Metabolism of cofactors and vitamins |
Pantothenate and CoA biosynthesis |
7 |
|
Metabolism of cofactors and vitamins |
Folate biosynthesis |
4 |
|
Metabolism of cofactors and vitamins |
Retinol metabolism |
8 |
|
Metabolism of cofactors and vitamins |
Porphyrin and chlorophyll metabolism |
14 |
|
Metabolism of terpenoids and polyketides |
Terpenoid backbone biosynthesis |
7 |
|
Metabolism of terpenoids and polyketides |
Limonene and pinene degradation |
6 |
|
Energy metabolism |
Nitrogen metabolism |
8 |
|
Energy metabolism |
Sulfur metabolism |
3 |
|
Xenobiotics biodegradation and metabolism |
Metabolism of xenobiotics by cytochrome P450 |
11 |
|
Xenobiotics biodegradation and metabolism |
Drug metabolism - cytochrome P450 |
10 |
|
Xenobiotics biodegradation and metabolism |
Drug metabolism - other enzymes |
14 |
|
Lipid metabolism |
Biosynthesis of unsaturated fatty acids |
14 |
|
Global and overview maps |
Metabolic pathways |
460 |
Pathway ID |
Pathway Class |
Description |
#PolymiRTS |
|
Endocrine system |
PPAR signaling pathway |
24 |
|
Immune system |
Chemokine signaling pathway |
81 |
|
Circulatory system |
Cardiac muscle contraction |
32 |
|
Circulatory system |
Vascular smooth muscle contraction |
48 |
|
Development |
Dorso-ventral axis formation |
18 |
|
Development |
Axon guidance |
62 |
|
Immune system |
Complement and coagulation cascades |
8 |
|
Immune system |
Antigen processing and presentation |
21 |
|
Endocrine system |
Renin-angiotensin system |
7 |
|
Immune system |
Toll-like receptor signaling pathway |
41 |
|
Immune system |
NOD-like receptor signaling pathway |
32 |
|
Immune system |
RIG-I-like receptor signaling pathway |
23 |
|
Immune system |
Cytosolic DNA-sensing pathway |
16 |
|
Immune system |
Hematopoietic cell lineage |
20 |
|
Immune system |
Natural killer cell mediated cytotoxicity |
48 |
|
Immune system |
T cell receptor signaling pathway |
60 |
|
Immune system |
B cell receptor signaling pathway |
45 |
|
Immune system |
Fc epsilon RI signaling pathway |
41 |
|
Immune system |
Fc gamma R-mediated phagocytosis |
50 |
|
Immune system |
Leukocyte transendothelial migration |
54 |
|
Immune system |
Intestinal immune network for IgA production |
9 |
|
Nervous system |
Long-term potentiation |
43 |
|
Nervous system |
Neurotrophin signaling pathway |
98 |
|
Nervous system |
Long-term depression |
31 |
|
Sensory system |
Olfactory transduction |
14 |
|
Sensory system |
Taste transduction |
7 |
|
Sensory system |
Phototransduction |
6 |
|
Endocrine system |
Insulin signaling pathway |
87 |
|
Endocrine system |
GnRH signaling pathway |
48 |
|
Endocrine system |
Progesterone-mediated oocyte maturation |
56 |
|
Endocrine system |
Melanogenesis |
40 |
|
Endocrine system |
Adipocytokine signaling pathway |
37 |
|
Excretory system |
Aldosterone-regulated sodium reabsorption |
22 |
|
Excretory system |
Vasopressin-regulated water reabsorption |
26 |
|
Excretory system |
Proximal tubule bicarbonate reclamation |
8 |
|
Excretory system |
Collecting duct acid secretion |
9 |